PegBio Co., Ltd. (HKG:2565)
Hong Kong
· Delayed Price · Currency is HKD 60.70
-1.30 (-2.10%)
Last updated: Mar 6, 2026, 3:30 PM HKT
PegBio Statistics
Total Valuation
PegBio has a market cap or net worth of HKD 23.50 billion. The enterprise value is 23.24 billion.
| Market Cap | 23.50B |
| Enterprise Value | 23.24B |
Important Dates
The next estimated earnings date is Monday, May 18, 2026.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PegBio has 391.09 million shares outstanding. The number of shares has increased by 38.53% in one year.
| Current Share Class | 284.30M |
| Shares Outstanding | 391.09M |
| Shares Change (YoY) | +38.53% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 24.20% |
| Owned by Institutions (%) | 22.84% |
| Float | 113.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 82.36 |
| P/TBV Ratio | 84.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -95.78 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -135.71 |
Financial Position
The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.32.
| Current Ratio | 3.08 |
| Quick Ratio | 2.99 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.54 |
| Interest Coverage | -77.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -81.87% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.18M |
| Employee Count | 58 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 66.16 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.22 |
| Average Volume (20 Days) | 254,398 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -242.96M |
| Pretax Income | -242.75M |
| Net Income | -242.62M |
| EBITDA | -241.98M |
| EBIT | -242.96M |
| Earnings Per Share (EPS) | -0.66 |
Balance Sheet
The company has 364.58 million in cash and 92.07 million in debt, giving a net cash position of 272.51 million or 0.70 per share.
| Cash & Cash Equivalents | 364.58M |
| Total Debt | 92.07M |
| Net Cash | 272.51M |
| Net Cash Per Share | 0.70 |
| Equity (Book Value) | 285.39M |
| Book Value Per Share | 0.72 |
| Working Capital | 255.91M |
Cash Flow
In the last 12 months, operating cash flow was -170.16 million and capital expenditures -1.08 million, giving a free cash flow of -171.24 million.
| Operating Cash Flow | -170.16M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -171.24M |
| FCF Per Share | -0.44 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PegBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.53% |
| Shareholder Yield | -38.53% |
| Earnings Yield | -1.03% |
| FCF Yield | -0.73% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |